Neurocrine Biosciences, Inc. (NBIX)
132.47
+0.87
(+0.66%)
USD |
NASDAQ |
Apr 06, 16:00
132.47
0.00 (0.00%)
After-Hours: 18:21
Neurocrine Biosciences Market Cap : 13.20B for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Glaukos Corp. | 6.791B |
| Edgewise Therapeutics, Inc. | 3.545B |
| Nuvalent, Inc. | 8.140B |
| Agenus, Inc. | 141.59M |
| Curis, Inc. | 22.32M |
Market Cap Related Metrics
| PE Ratio | 28.38 |
| PS Ratio | 4.743 |
| PEG Ratio | 0.6785 |
| Price to Book Value | 4.087 |
| Price to Free Cash Flow | 18.12 |
| Price | 132.47 |
| Earnings Yield | 3.52% |
| PEGY Ratio | 0.6785 |
| Operating PE Ratio | 21.32 |
| Normalized PE Ratio | 27.52 |